Article
Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance
14 Jul 2017
Abstract excerpt
Chronic myelomonocytic leukemia (CMML) is an aggressive hematologic malignancy with overlapping features of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms.1, 2 Patients with CMML, display between 10 and 15 mutations per kilobase of coding DNA regions; with majority of these (>90%) involving epigenetic regulator genes (TET2 60%, ASXL1 40%), splicing machinery (SRSF2 40%), and cell signaling...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
